These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 729630)

  • 21. Depression of maximum rate of depolarization of guinea-pig ventricular action potentials by metabolites of encainide.
    Hemsworth PD; Campbell TJ
    Br J Pharmacol; 1989 Jun; 97(2):619-25. PubMed ID: 2503225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ouabain-induced changes in electrophysiologic properties of neonatal, young and adult canine cardiac Purkinje Fibers.
    Rosen MR; Hordof AJ; Hodess AB; Verosky M; Vulliemoz Y
    J Pharmacol Exp Ther; 1975 Jul; 194(1):255-63. PubMed ID: 1151753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers.
    Turgeon J; Funck-Brentano C; Gray HT; Pavlou HN; Prakash C; Blair IA; Roden DM
    Clin Pharmacol Ther; 1991 May; 49(5):488-96. PubMed ID: 1903098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiological effects of sulfinpyrazone on canine cardiac Purkinje fibers.
    Benditt DG; Grant AO; Hutchison AB; Strauss HC
    Can J Physiol Pharmacol; 1980 Jun; 58(6):738-42. PubMed ID: 7427792
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of disobutamide on electrophysiologic properties of canine cardiac Purkinje fibers and papillary muscle.
    Dohrmann ML; Harrell FE; Strauss HC
    J Pharmacol Exp Ther; 1981 Jun; 217(3):549-54. PubMed ID: 7229991
    [No Abstract]   [Full Text] [Related]  

  • 27. Cellular electrophysiology of the new antiarrhythmic agent recainam (Wy-42,362) in canine cardiac Purkinje fibers.
    Colatsky TJ; Bird LB; Jurkiewicz NK; Wendt RL
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):435-44. PubMed ID: 2438506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ethmozin on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electrophysiologic matrix.
    Arnsdorf MF; Sawicki GJ
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1158-66. PubMed ID: 2495352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological effects of carocainide (770207) on canine ventricular muscle and Purkinje fibers.
    Pourrias B; Santamaria R
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):85-95. PubMed ID: 6316863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C.
    Wit AL; Hoffman BF; Rosen MR
    Am Heart J; 1975 Dec; 90(6):795-803. PubMed ID: 903
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrophysiological studies of 6-(N,N-diethylamino)-Hexyl-3,4,5,-Trimethoxybenzoate on ventricular muscle and conduction system.
    Posner P; Chiou CY
    Pharmacology; 1976; 14(2):97-103. PubMed ID: 959320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic peptide has no direct cardiac actions.
    Argentieri T; Cantor E; Wiggins JR
    Experientia; 1989 Aug; 45(8):737-8. PubMed ID: 2759204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of low dose ouabain on canine Purkinje fibers.
    Moe BH; Lurie PR; Giddings JA; Stanton RE; Cosby RS
    Proc West Pharmacol Soc; 1981; 24():67-8. PubMed ID: 7255488
    [No Abstract]   [Full Text] [Related]  

  • 34. Membrane action of ethmozin on normoxic and hypoxic canine Purkinje fibers.
    Tsuji Y; Nishimura M; Osada M; Watanabe Y
    J Cardiovasc Pharmacol; 1983; 5(6):961-7. PubMed ID: 6196568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: The effects of ouabain on interval duration relationships in sheep Purkinje fibres.
    Cohen I; Daut J; Noble D
    J Physiol; 1976 Jan; 254(1):45P-46P. PubMed ID: 1249745
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs.
    Pallandi RT; Campbell TJ
    Cardiovasc Res; 1988 Mar; 22(3):171-8. PubMed ID: 3167941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: The influence of extracellular potassium ions on the action of ouabain on membrane currents in sheep Purkinje fibres.
    Cohen I; Daut J; Noble D
    J Physiol; 1975 Jul; 249(1):42P-43P. PubMed ID: 1151872
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effects of a new orally active antidysrhythmic agent, Organon 6001, on the cardiac action potential of human ventricular muscle and sheep Purkinje fibres [proceedings].
    Kane KA
    Br J Pharmacol; 1977 Nov; 61(3):457P-458P. PubMed ID: 588815
    [No Abstract]   [Full Text] [Related]  

  • 39. The contribution of cellular electrophysiology in the development of antiarrhythmic agents.
    Spear JF; Moore EN
    Pacing Clin Electrophysiol; 1982 Mar; 5(2):238-50. PubMed ID: 6176964
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of ouabain on the transmembrane potentials and intracellular potassium activity of canine cardiac Purkinje fibers.
    Miura DS; Rosen MR
    Circ Res; 1978 Mar; 42(3):333-8. PubMed ID: 624138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.